Pinealon research peptide – Pinealon (Glu-Asp-Arg, EDR) is a Khavinson short-peptide bio

Pinealon

Pinealon (Glu-Asp-Arg, EDR) is a Khavinson short-peptide bioregulator studied for neuroprotection, melatonin support and reduced neuronal oxidative stress.

CognitiveAnti-Aging
In Stock

Total Price

฿1700

CardCryptoEncrypted checkout

For research & laboratory use only. Not for human consumption.

Half-Life

~1-2 hours

Administration Route

Subcutaneous injection or oral

Pineal Gland Peptide

Khavinson tripeptide targeting pineal gland gene expression

Melatonin Restoration

Supports age-related decline in pineal melatonin production

Neuroprotection

Reduces neuronal oxidative stress and supports glial health

Mechanism of Action

Pinealon is a synthetic tripeptide (Glu-Asp-Arg, the EDR sequence) belonging to the Khavinson family of short-peptide bioregulators derived from pineal gland sequences. Because it is small enough to cross the cell and nuclear membranes, EDR reaches the genome directly and binds promoter regions of pineal-relevant genes, acting as a transcriptional switch rather than a receptor ligand. It up-regulates arylalkylamine N-acetyltransferase (AANAT), the rate-limiting enzyme of melatonin synthesis, and Nrf2-controlled antioxidant genes such as heme oxygenase-1, superoxide dismutase and catalase. By raising antioxidant capacity and supporting survival genes of the Bcl-2 family, Pinealon lowers oxidative stress-induced apoptosis and reduces the build-up of lipofuscin in post-mitotic neurons, two processes central to brain aging.

Scientific Research

Mechanism: Nuclear Penetration and Gene Activation

Pinealon’s proposed mechanism involves:

  1. Cellular uptake via endocytosis or direct membrane penetration (small peptides can enter cells through transporter proteins)
  2. Nuclear localisation - EDR interacts with histone-associated chromatin
  3. Binding to promoter regions of pineal-specific genes
  4. Transcriptional activation of:
    • AANAT (arylalkylamine N-acetyltransferase, rate-limiting for melatonin synthesis)
    • Nrf2-regulated antioxidant genes (HO-1, SOD, catalase)
    • Survival genes in neurons (Bcl-2 family)

Evidence for this mechanism comes from both cell culture studies and animal models showing Pinealon-induced increases in antioxidant enzyme expression and reductions in lipofuscin accumulation.

Lipofuscin and Neuronal Aging

Lipofuscin is a fluorescent waste material that accumulates in post-mitotic cells (neurons, cardiomyocytes) as a result of incomplete lysosomal degradation of oxidised proteins. Its accumulation is a hallmark of cellular aging and is associated with reduced neuronal function. Pinealon has been shown in multiple studies to reduce lipofuscin content in brain tissue of aged animals - suggesting it either reduces oxidative damage that generates lipofuscin or enhances lysosomal/proteasomal clearance.

Combination with Epithalon

The Khavinson group has studied combinations of their peptide bioregulators extensively:

  • Epithalon (AEDG): thymus-derived, systemic telomerase activation and immune modulation
  • Pinealon (EDR): pineal-derived, brain and melatonin axis support

Together they are reported to produce additive anti-aging effects in both animal models and long-term human observational studies.

Reconstitution and Storage

Reconstitution: reconstitute the vial with bacteriostatic water; swirl gently until dissolved, do not shake. After reconstitution: keep refrigerated, protect from direct light, and use within 28 days.

For research purposes only. Not for human consumption.

Dosing at a Glance

Route

Subcutaneous injection or oral

Frequency

Once daily

Typical research dose

200–400 mcg

Calculate dosage

Opens the calculator with this peptide preselected. Research reference only.

Product FAQs

Stacks Well With

Related Products

Cart

Your cart is empty